Works by Wang, Xiao-Shan


Results: 10
    1
    2
    3
    4

    Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 742, doi. 10.1093/jnci/djac015
    By:
    • Wang, Xiao-Shan;
    • Bai, Yi-Feng;
    • Verma, Vivek;
    • Yu, Rui-Lian;
    • Tian, Wei;
    • Ao, Rui;
    • Deng, Ying;
    • Zhu, Xue-Qiang;
    • Liu, Hao;
    • Pan, Hai-Xia;
    • Yang, Lan;
    • Bai, Han-Song;
    • Luo, Xing;
    • Guo, Yan;
    • Zhou, Ming-Xiu;
    • Sun, Yue-Mei;
    • Zhang, Zi-Can;
    • Li, Si-Min;
    • Cheng, Xue;
    • Tan, Bang-Xian
    Publication type:
    Article
    5
    6
    7
    8
    9
    10